NMRA
Neumora Therapeutics: Charting a Course for Breakthroughs in Brain Diseases
Neumora Therapeutics has just concluded its fourth quarter and full year 2025 financial results conference call, and the company's prospects look brighter than ever. With a diverse pipeline of novel mechanism therapies advancing steadily, Neumora is poised to revolutionize the treatment of brain diseases. The company's